Injectable third party manufacturing lets you sell vials, ampoules and pre-filled injections under your own brand without building a costly sterile facility of your own. You own the brand and product list; a certified contract manufacturer formulates, fills, sterilises, tests and packs the injectables to your specifications. For distributors, marketing companies and PCD partners in India, this is the fastest, lowest-risk way to add a high-value injectable range. This guide explains the types of injectables, why they demand higher compliance, how the process works, the documents and MOQ involved, packaging, and what drives pricing.
Key takeaways (TL;DR)
- Injectable third party manufacturing = your brand, a certified sterile facility handles production.
- Main types: dry powder/lyophilized vials, liquid vials, ampoules, and pre-filled syringes.
- Injectables need sterile manufacturing and stricter WHO-GMP/Schedule M compliance than oral forms.
- The essentials to begin are a Drug License, GST registration and brand/trademark details.
- Pricing depends on the molecule, injectable type, MOQ, packaging and quality/export specs.
What is injectable third party manufacturing?
Injectable third party manufacturing — also called injectable contract manufacturing or loan-licensing — is an arrangement where a company gets its injectable products made by a separate, licensed manufacturer with a sterile facility instead of producing them in-house. You provide the brand name, the product list and packaging design; the manufacturer handles formulation, sterile filling, quality control and packing at a certified facility.
This model suits marketing companies, PCD franchise owners, distributors and entrepreneurs who want a branded injectable range for hospital, critical-care and specialty segments — without the heavy capital, sterile-area licensing and compliance burden of owning an injectable plant.
Types of injectables you can get manufactured
| Injectable type | Description | Typical use |
|---|---|---|
| Dry powder / lyophilized vials | Powder or freeze-dried product reconstituted before use; better stability for sensitive molecules | Antibiotics, certain specialty and critical-care ranges |
| Liquid (small-volume) vials | Ready-to-use sterile solution filled into glass vials | Hospital and general injectable ranges |
| Ampoules | Single-dose sealed glass units for liquid injectables | Single-dose, emergency and OT use |
| Pre-filled syringes | Pre-measured, ready-to-administer sterile dose | Convenience, specialty and self-administration ranges |
Why injectables need higher compliance and sterile facilities
Because injectables bypass the body’s natural barriers and enter directly into tissue or the bloodstream, they must be manufactured under far stricter conditions than tablets or syrups. The product has to be sterile and free of particulate matter and pyrogens, which is why injectable production sits in a separate, tightly controlled part of compliance.
- Sterile / aseptic areas: classified cleanrooms with controlled air, HEPA filtration and environmental monitoring.
- WHO-GMP & Schedule M: dedicated sterile-block requirements over and above oral-form standards.
- Validated processes: sterilisation, filling and lyophilisation cycles are validated and documented.
- Rigorous QC: sterility, pyrogen/endotoxin, particulate and stability testing on every batch.
- Trained personnel: gowning, aseptic technique and strict access control in the fill-finish area.
This is why partnering with an established WHO-GMP and DCGI-compliant manufacturer matters even more for injectables than for oral forms — the cost of a compliance lapse is far higher.
How the injectable manufacturing process works
| Step | What happens |
|---|---|
| 1. Enquiry & product selection | Share your required injectables, types (vial/ampoule/PFS) and quantities. |
| 2. Quotation | Manufacturer shares net rates, MOQ and timelines for each product. |
| 3. Documentation | Submit Drug License, GST and brand/trademark details. |
| 4. Packaging & artwork | Approve vial/ampoule labels, mono-cartons, inserts and shipper design. |
| 5. Sterile manufacturing & QC | Aseptic filling, sterilisation/lyophilisation and full quality testing at the certified facility. |
| 6. Packing & dispatch | Finished, labelled and batch-cleared stock is packed and shipped to you. |
Documents required
- Drug License Number (wholesale or manufacturing, as applicable)
- GST registration
- Brand name & trademark (TM) details for your injectable products
- Product list with required compositions, injectable type and packaging
- Any additional state or export documentation, where relevant
MOQ, packaging and what drives pricing
Injectables generally carry higher MOQs and per-unit costs than tablets because batches run in sterile lines with stringent quality release. Packaging also adds cost: vials and ampoules need labels, while ready packs use mono-cartons with inserts and tamper-evident shippers.
| Factor | Effect on cost / order |
|---|---|
| Molecule / composition | Active ingredient cost varies widely by product |
| Injectable type | Lyophilized/dry powder and pre-filled syringes typically cost more than liquid vials |
| Order quantity (MOQ) | Larger sterile batches lower the per-unit cost |
| Packaging | Vial/ampoule labels, mono-cartons, inserts and shippers add cost |
| Quality & export specs | Higher specs (e.g. export-grade) increase cost and testing |
Figures and MOQs vary by product and manufacturer — always confirm exact terms for your requirement.
Regulatory considerations to keep in mind
Marketing injectables under your brand in India is governed by the same drug-regulatory framework as other formulations, with extra weight on sterile-area compliance. From a commercial standpoint, the key is to ensure your partner’s products and facility are properly approved and that your own licensing is in order.
- Valid Drug License appropriate to your activity (wholesale/marketing or manufacturing).
- GST registration and accurate product/brand documentation.
- Partner facility holding WHO-GMP, ISO and DCGI-approved product status, with Schedule M sterile compliance.
- Correct labelling, batch numbers, manufacturing/expiry details and statutory declarations on packs.
- Additional approvals where you plan to export to specific markets.
This is commercial guidance on sourcing and compliance, not legal advice — confirm current regulatory requirements with the manufacturer and your advisors.
Why partner with Kroyf Labs for injectables
Kroyf Labs brings 16+ years of experience, 1350+ associates, and a 400+ DCGI & FSSAI-approved product range, with WHO-GMP, ISO and FDA-standard manufacturing across injectables, tablets, capsules, softgels, syrups, eye/ear drops, ointments and nutraceuticals. We support segments from antibiotics and critical care to cardiology, dermatology and neurology — with reliable pan-India supply from our Mumbai headquarters and Panchkula operations.
Looking to add a branded injectable range? Request a manufacturing quote from Kroyf Labs →
Frequently asked questions
What is injectable third party manufacturing?
It is an arrangement where you get injectables made under your own brand by a separate licensed manufacturer with a sterile facility, instead of producing them in-house. You own the brand; they handle sterile production, quality control and packing.
What types of injectables can be manufactured?
Common types include dry powder and lyophilized vials, liquid (small-volume) vials, ampoules, and pre-filled syringes, covering hospital, critical-care and specialty ranges.
Why do injectables need higher compliance than tablets?
Injectables enter the body directly, so they must be sterile and free of pyrogens and particulates. They are made in classified sterile cleanrooms under stricter WHO-GMP and Schedule M requirements, with validated processes and rigorous batch testing.
What documents are needed to start?
A Drug License and GST registration are the essentials, along with your brand/trademark details and a product list with compositions, injectable type and packaging requirements.
What is the minimum order quantity for injectables?
MOQ depends on the injectable type and product, and is generally higher than for tablets because of sterile batch runs. Larger order quantities reduce the per-unit cost. Confirm the exact MOQ for each product with the manufacturer.
Author: Kroyf Labs Editorial Team — insights based on Kroyf Labs’ 16+ years in pharmaceutical manufacturing and PCD franchise across India. This article is general business information and not medical or legal advice. Figures are indicative; confirm exact terms with the manufacturer.
